Fingerpaint, biopharma’s global commercialization partner for analytics-enabled integrated solutions, was named to Adweek’s Fastest-Growing Agencies list.
“Being recognized as one of the fastest-growing businesses in the industry is proof of our staunch commitment to evolving our integrated solutions to meet our client’s ever-changing needs,”said Bill McEllen, a partner at Fingerpaint. “Our people will never stop innovating on behalf of our clients.”
With a projected revenue of more than $130 million in 2021, Fingerpaint’s year-over-year growth includes the acquisition of 1798, a market access and commercialization firm; the launch of Photo 51, a consultancy focused solely on advanced therapeutics, such as gene and cell therapies, and strategic investment in Leaderboard Branding, a leading global naming and branding business. Most recently, Fingerpaint expanded its presence on the West Coast by acquiring an award-winning agency based in the Bay Area.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.